CEACAM5 and large cell neuroendocrine carcinoma: We provide the landscape of tumor relapse and adjuvant therapy for resected LCNEC and confirmed PE was a priority for these patients; furthermore, normal serum tumor markers such as CEA and NSE could be utilized for prognosis evaluation, which was convenient and non-invasive for clinical practice.